Mckesson Corp
NYSE:MCK
Mckesson Corp
Revenue
Mckesson Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mckesson Corp
NYSE:MCK
|
Revenue
$301.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
Cardinal Health Inc
NYSE:CAH
|
Revenue
$216.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
Owens & Minor Inc
NYSE:OMI
|
Revenue
$10.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Revenue
$12.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Revenue
$6.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
Cencora Inc
NYSE:COR
|
Revenue
$271.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
Mckesson Corp
Revenue Breakdown
Breakdown by Geography
Mckesson Corp
Breakdown by Segments
Mckesson Corp
Total Revenue:
276.7B
USD
|
United States Pharmaceutical:
240.6B
USD
|
International:
20.6B
USD
|
Medical-Surgical Solutions:
11.1B
USD
|
Prescription Technology Solutions:
4.4B
USD
|
See Also
What is Mckesson Corp's Revenue?
Revenue
301.5B
USD
Based on the financial report for Dec 31, 2023, Mckesson Corp's Revenue amounts to 301.5B USD.
What is Mckesson Corp's Revenue growth rate?
Revenue CAGR 10Y
9%
Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Mckesson Corp have been 8% over the past three years , 7% over the past five years , and 9% over the past ten years .